Features & Benefits
Genes analyzed
-
LDLR
-
APOB
-
PCSK9
-
LDLRAP1
-
APOE
-
STAP1
Polygenic FH SNPs analyzed
-
rs629301
-
rs1564348
-
rs1800562
-
rs2479409
-
rs3757354
-
rs4299376
-
rs6511720
-
rs8017377
-
rs11220462
-
rs1367117
-
rs429358
-
rs7412
Sequencing of six SNPs involved in statin response
-
rs429358
-
rs7412
-
rs646776
-
rs4149056
-
rs3798220
-
rs10455872
Devyser FH NGS
Devyser FH NGS enables analysis of sequence variants in human genes implicated in Familial Hypercholesterolemia (FH) and polymorphisms associated with statin treatment effect.
For further information on the Devyser FH NGS Kit, click here.
To download the Devyser FH NGS Kit handbook, click here.
Features & Benefits
-
Identify genetic basis of thrombotic event
-
Aid in therapy selection
-
Treatment optimisation
-
Determine need for prophylaxis
-
Estimate future thrombotic risk
Devyser Thrombophilia
The Devyser Thrombophilia assay offers a very simple procedure for testing six relevant mutations implicated in the risk of developing thrombophilia and venous thromboembolism.
It is a multiplex PCR reagent kit for simultaneous detection of six genetic risk factors associated with thrombophilia
For further information on the Devyser Thrombophilia Kit, click here.
To download the Devyser Thrombophilia Kit handbook, click here.
Features & Benefits
-
Single tube PCR minimizes hands-on time
-
Single tube PCR reduces analysis times while minimizing the risk of sample mix up
-
A single mix allows testing of seven relevant risk factors for cardiovascular disease
Devyser CVD
Devyser CVD is an in vitro diagnostic product for qualitative detection of genetic risk factors for the development of cardiovascular disease (CVD).
For further information on the Devyser CVD, click here.
To download the Devyser CVD handbook, click here.
